Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden

References

• Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933–51.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum beta- lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657–86.
   PubMed Web of Science ®Google Scholar
• The European Antimicrobial Resistance Surveillance System (EARSS). Annual report 2007. EARSS, Bilthoven, The Netherlands 2007;58–71.
   Google Scholar
• Bonnet R. Growing group of extended-spectrum beta- lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1–14.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, . CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59: 165–74.
   PubMed Web of Science ®Google Scholar
• β-Lactamase Classification and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant Enzymes. http://www.lahey.org/studies. Accessed 15th December 2009.
   Google Scholar
• Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(Suppl 1):144–53.
   PubMed Web of Science ®Google Scholar
• Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13:1–11.
   Google Scholar
• Alsterlund R, Carlsson B, Gezelius L, Haeggman S, Olsson-Liljequist B. Multiresistant CTX-M-15 ESBL- producing Escherichia coli in southern Sweden: description of an outbreak. Scand J Infect Dis 2009;41:410–5.
   PubMed Web of Science ®Google Scholar
• Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, . Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004;48:3758–64.
   PubMed Web of Science ®Google Scholar
• Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008;116:302–8.
   PubMed Web of Science ®Google Scholar
• Mamlouk K, Boutiba-Ben Boubaker I, Gautier V, Vimont S, Picard B, Ben Redjeb S, Arlet G. Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 2006;44:4049–56.
   PubMedGoogle Scholar
• Naseer U, Natas OB, Haldorsen BC, Bue B, Grundt H, Walsh TR, Sundsfjord A. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS 2007;115:120–6.
   PubMed Web of Science ®Google Scholar
• Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, . Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004; 54:735–43.
   PubMed Web of Science ®Google Scholar
• Forssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, . Emergence of ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates during the years 2000 and 2004 in Helsinki, Finland. Clin Microbiol Infect 2009; [Published online 14 Oct 2009].
   Google Scholar
• Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, . A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278–82.
   PubMed Web of Science ®Google Scholar
• Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, . Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000;46:223–8.
   PubMed Web of Science ®Google Scholar
• Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect 2009;15(Suppl 3):12–5.
   PubMed Web of Science ®Google Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579–87.
   PubMed Web of Science ®Google Scholar
• van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008;14:1722–30.
   PubMed Web of Science ®Google Scholar
• Urbanek K, Kolar M, Loveckova Y, Strojil J, Santava L. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J Clin Pharm Ther 2007;32:403–8.
   PubMed Web of Science ®Google Scholar
• The Swedish Reference Group for Antibiotics (SRGA) and Subcommittee on Methodology (SRGA-M). Disk diffusion. SRGA; 2009. Available at: http://www.srga.org/RAFMETOD/rafmet.htm (Accessed 3rd September 2009).
   Google Scholar
• Monstein HJ, Tarnberg M, Nilsson LE. Molecular identification of CTX-M and blaOXY/K1 beta-lactamase genes in Enterobacteriaceae by sequencing of universal M13-sequence tagged PCR-amplicons. BMC Infect Dis 2009;9:7.
   PubMedGoogle Scholar
• World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses. Oslo, Norway: WHO; 2005.
   Google Scholar
• Capella D. Descriptive tools and analysis. WHO Reg Publ Eur Ser 1993;45:55–78.
   PubMedGoogle Scholar
• The European Antimicrobial Resistance Surveillance System (EARSS). EARSS interactive database access. Available at: http://www.rivm.nl/earss/database (Accessed 6th October 2009).
   Google Scholar
• Kjerulf A, Hansen DS, Sandvang D, Hansen F, Frimodt-Moller N. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS 2008;116:118–24.
   PubMed Web of Science ®Google Scholar
• Danish Integrated Antimicrobial resistance Monitoring and Research Programme (DANMAP). Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Copenhagen: DANMAP; 2007.
   Google Scholar
• NORM/NORM-VET Tromsø/Oslo. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway; 2007.
   Google Scholar
• SWEDRES. The Swedish Strategic Programme against Antibiotic Resistance and the Swedish Institute for Infectious Disease Control, Solna, Sweden. A report on Swedish antimicrobial utilisation and resistance in human medicine; 2007.
   Google Scholar
• Borg MA, van de Sande-Bruinsma N, Scicluna E, de Kraker M, Tiemersma E, Monen J, Grundmann H. Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect 2008;14:789–96.
   PubMedGoogle Scholar
• Hallgren H, Gustafsson I, Ripa T. [ESBL—increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections]. Lakartidningen 2007;104:3883–5.
   PubMedGoogle Scholar
• Rossolini GM, D’Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 2008;14(Suppl 1):33–41.
   PubMedGoogle Scholar
• Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159–66.
   PubMed Web of Science ®Google Scholar
• Nyberg SD, Osterblad M, Hakanen AJ, Huovinen P, Jalava J. The Finnish Study Group for Antimicrobial Resistance. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002–2004. Scand J Infect Dis 2007;39:417–24.
   PubMed Web of Science ®Google Scholar
• Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 2008;46:707–12.
   PubMed Web of Science ®Google Scholar
• Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A. Effects of phenotype and genotype on methods for detection of extended- spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007;45:199–205.
   PubMed Web of Science ®Google Scholar
• Andre M, Vernby A, Odenholt I, Lundborg CS, Axelsson I, Eriksson M, . Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: consultations, diagnosis, diagnostics and treatment choices. Scand J Infect Dis 2008;40:648–54.
   PubMed Web of Science ®Google Scholar
• Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea. Scand J Infect Dis 2010;42:275–80.
   PubMed Web of Science ®Google Scholar